TDIQ

Last updated
TDIQ
TDIQ.svg
Clinical data
Other names6,7-Methylenedioxy-1,2,3,4-tetrahydroisoquinoline; 6,7-Methylenedioxy-THIQ; MDTHIQ; MDA-CR; "MDA-Conformationally Restricted"; MDA-THIQ; MDA/THIQ
Identifiers
  • 5,6,7,8-Tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C10H11NO2
Molar mass 177.203 g·mol−1
3D model (JSmol)
  • c23OCOc2cc1CCNCc1c3
  • InChI=1S/C10H11NO2/c1-2-11-5-8-4-10-9(3-7(1)8)12-6-13-10/h3-4,11H,1-2,5-6H2
  • Key:JHLDJOBIUVJSTG-UHFFFAOYSA-N
   (verify)

TDIQ, also known as MDTHIQ or MDA-CR, is a tetrahydroisoquinoline drug used in scientific research, which has anxiolytic and anorectic effects in animals. [1] [2] It has an unusual effects profile in animals, with the effects generalising to cocaine and partially to MDMA and ephedrine, [3] but the effects did not generalise to amphetamine and TDIQ does not have any stimulant effects. [4] It is thought these effects are mediated via a partial agonist action at α2-adrenergic receptors, and TDIQ has been suggested as a possible drug for the treatment of cocaine dependence. [5]

See also

References

  1. ↑ Young R, Rothman RB, Rangisetty JB, Partilla JS, Dukat M, Glennon RA (May 2006). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) inhibits the consumption of "snacks" in mice". Pharmacology Biochemistry and Behavior. 84 (1): 74–83. doi:10.1016/j.pbb.2006.04.007. PMID   16750261. S2CID   22564648.
  2. ↑ Young R, Batkai S, Dukat M, Glennon RA (May 2006). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice". Pharmacology Biochemistry and Behavior. 84 (1): 62–73. doi:10.1016/j.pbb.2006.04.006. PMID   16750844. S2CID   12307882.
  3. ↑ Young R, Glennon RA (2002). "The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine". Pharmacology Biochemistry and Behavior. 71 (1–2): 205–13. CiteSeerX   10.1.1.670.8659 . doi:10.1016/S0091-3057(01)00666-9. PMID   11812524. S2CID   16553365.
  4. ↑ Glennon RA, Young R, Rangisetty JB (May 2002). "Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline". Pharmacology Biochemistry and Behavior. 72 (1–2): 379–87. doi:10.1016/S0091-3057(01)00768-7. PMID   11900809. S2CID   33311107.
  5. ↑ Young R (2007). "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potential". CNS Drug Reviews. 13 (4): 405–22. doi:10.1111/j.1527-3458.2007.00022.x. PMC   6494129 . PMID   18078426.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.